Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
Sentrin specific-protease 1 (SENP1) is a protein involved in deSUMOylation that is almost overexpressed in cancer. SENP1 has a determinative role in the activation of transcription programs in the innate immune responses and the development B of and C lymphocytes. We found, SENP1 possibly plays a cr...
Main Authors: | Somayye Taghvaei, Farzaneh Sabouni, Zarrin Minuchehr |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.700454/full |
Similar Items
-
Computational study of SENP1 in cancer by novel natural compounds and ZINC database screening
by: Somayye Taghvaei, et al.
Published: (2023-07-01) -
Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort
by: Yi Liu, et al.
Published: (2021-11-01) -
SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
by: Youzhi Zhu, et al.
Published: (2023-01-01) -
Evidence of Omics, Immune Infiltration, and Pharmacogenomics for BATF in a Pan-Cancer Cohort
by: Chenguang Jia, et al.
Published: (2022-04-01) -
UCP1 modulates immune infiltration level and survival outcome in ovarian cancer patients
by: Jinfa Huang, et al.
Published: (2022-01-01)